Goat anti-PKD1 / Polycystin 1
EB08670
ApplicationsImmunoFluorescence, ImmunoPrecipitation, ELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetPKD1
Overview
- SupplierEverest Biotech
- Product NameGoat anti-PKD1 / Polycystin 1 Antibody
- Delivery Days Customer5
- Application Supplier NoteImmunoprecipitation: This antibody was successfully used on Human (PMID:25574838, and PMID: 29706351). Immunofluorescence: This antibody was successfully used in IF on Human (Durand et al, Sci Rep. 2016 Oct 24;6:35963, PMID: 27775029).
- ApplicationsImmunoFluorescence, ImmunoPrecipitation, ELISA, ImmunoHistoChemistry
- Applications SupplierPep-ELISA, IHC, IP, IF
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5 mg/ml
- Gene ID5310
- Target namePKD1
- Target descriptionpolycystin 1, transient receptor potential channel interacting
- Target synonymsautosomal dominant polycystic kidney disease 1 protein; PBP; PC1; Pc-1; polycystic kidney disease 1 (autosomal dominant); polycystic kidney disease-associated protein; polycystin-1; transient receptor potential cation channel, subfamily P, member 1; TRPP1
- HostGoat
- Scientific DescriptionRefSeq number(s): NP_001009944.1; NP_000287.2. Purification: Antigen affinity purified. Names and symbols: PKD1; polycystic kidney disease 1 (autosomal dominant); PBP; polycystic kidney disease-associated protein; polycystin 1
- ReactivityHuman
- Reactivity SupplierHuman
- Storage Instruction-20°C
- UNSPSC12352203
References
- Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease. Cornec-Le Gall E et al., 2018 May 3, Am J Hum GenetRead more
- Protein Kinase D1 regulates focal adhesion dynamics and cell adhesion through Phosphatidylinositol-4-phosphate 5-kinase type-l gamma. Durand N et al., 2016 Oct 24, Sci RepRead more
- The PRKD1 promoter is a target of the KRas-NF-kappaB pathway in pancreatic cancer. Doeppler H et al., 2016 Sep 21, Sci RepRead more
- Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner. Gainullin VG et al., 2015 Feb, J Clin InvestRead more